ETON
Price
$27.63
Change
+$0.22 (+0.80%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
785.61M
64 days until earnings call
Intraday BUY SELL Signals
FDMT
Price
$9.54
Change
+$0.27 (+2.91%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
507.6M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ETON vs FDMT

Header iconETON vs FDMT Comparison
Open Charts ETON vs FDMTBanner chart's image
ETON vs FDMT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ETON vs. FDMT commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETON is a StrongBuy and FDMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (ETON: $27.34 vs. FDMT: $9.27)
Brand notoriety: ETON and FDMT are both not notable
ETON represents the Pharmaceuticals: Generic, while FDMT is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETON: 99% vs. FDMT: 121%
Market capitalization -- ETON: $785.61M vs. FDMT: $507.6M
ETON [@Pharmaceuticals: Generic] is valued at $785.61M. FDMT’s [@Biotechnology] market capitalization is $507.6M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.89B. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETON’s FA Score shows that 2 FA rating(s) are green whileFDMT’s FA Score has 1 green FA rating(s).

  • ETON’s FA Score: 2 green, 3 red.
  • FDMT’s FA Score: 1 green, 4 red.
According to our system of comparison, ETON is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETON’s TA Score shows that 4 TA indicator(s) are bullish while FDMT’s TA Score has 3 bullish TA indicator(s).

  • ETON’s TA Score: 4 bullish, 5 bearish.
  • FDMT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ETON is a better buy in the short-term than FDMT.

Price Growth

ETON (@Pharmaceuticals: Generic) experienced а -12.62% price change this week, while FDMT (@Biotechnology) price change was +6.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.16%. For the same industry, the average monthly price growth was +24.29%, and the average quarterly price growth was +16.47%.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

ETON is expected to report earnings on Aug 06, 2026.

FDMT is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-2.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETON($786M) has a higher market cap than FDMT($508M). ETON YTD gains are higher at: 61.679 vs. FDMT (23.600). ETON has higher annual earnings (EBITDA): 6.2M vs. FDMT (-171.62M). FDMT has more cash in the bank: 391M vs. ETON (19.7M). FDMT has less debt than ETON: FDMT (20.5M) vs ETON (31.2M). FDMT (88.2M) and ETON (86.9M) have equivalent revenues.
ETONFDMTETON / FDMT
Capitalization786M508M155%
EBITDA6.2M-171.62M-4%
Gain YTD61.67923.600261%
P/E Ratio124.00N/A-
Revenue86.9M88.2M99%
Total Cash19.7M391M5%
Total Debt31.2M20.5M152%
FUNDAMENTALS RATINGS
ETON: Fundamental Ratings
ETON
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
17
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETONFDMT
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
83%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ETON
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRILX59.930.06
+0.10%
Parnassus Core Equity Institutional
HNTVX62.36N/A
N/A
Heartland Value Institutional
JDURX15.13N/A
N/A
PGIM Jennison Utility R
GSXIX50.61N/A
N/A
abrdn US Small Cap Equity Inst Svc
LSOFX18.33N/A
N/A
LS Opportunity Fund Institutional Class

ETON and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETON has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ETON jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETON
1D Price
Change %
ETON100%
-4.67%
MDGL - ETON
34%
Loosely correlated
-5.90%
VKTX - ETON
31%
Poorly correlated
-6.33%
ARRY - ETON
30%
Poorly correlated
+4.54%
FDMT - ETON
29%
Poorly correlated
-4.53%
KYMR - ETON
27%
Poorly correlated
-9.15%
More

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with KYTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-4.53%
KYTX - FDMT
48%
Loosely correlated
-4.01%
RCKT - FDMT
46%
Loosely correlated
-4.30%
KRYS - FDMT
40%
Loosely correlated
-1.61%
EQ - FDMT
40%
Loosely correlated
-9.42%
SLDB - FDMT
39%
Loosely correlated
-8.48%
More